Biguanide-transition metals complexes as potential drug for hyperglycemia treatment

ABSTRACT: Coordination compounds of Cu(ii), Ni(ii), Co(ii), and Zn(ii) with a type of biguanide (known commercially as metformin) have been synthesized and characterized using spectroscopic techniques (FT-IR, UV/VIS), X-ray diffraction techniques and thermal analysis. For all compounds, single cryst...

Full description

Autores:
Balcázar Morales, Norman
Villamizar Delgado, Stephanny
Porras Osorio, Laura M.
Piñeros, Octavio
Ellena, Javier
Varela Miranda, Rubén E.
D'Vries, Richard F.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2020
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/41104
Acceso en línea:
https://hdl.handle.net/10495/41104
Palabra clave:
Hiperglucemia
Hyperglycemia
Biguanidas
Biguanides
Metformina
Metformin
https://id.nlm.nih.gov/mesh/D006943
https://id.nlm.nih.gov/mesh/D001645
https://id.nlm.nih.gov/mesh/D008687
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc/4.0/
id UDEA2_c0d637c41dea417990576d283d43d2d4
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/41104
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
title Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
spellingShingle Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
Hiperglucemia
Hyperglycemia
Biguanidas
Biguanides
Metformina
Metformin
https://id.nlm.nih.gov/mesh/D006943
https://id.nlm.nih.gov/mesh/D001645
https://id.nlm.nih.gov/mesh/D008687
title_short Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
title_full Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
title_fullStr Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
title_full_unstemmed Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
title_sort Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
dc.creator.fl_str_mv Balcázar Morales, Norman
Villamizar Delgado, Stephanny
Porras Osorio, Laura M.
Piñeros, Octavio
Ellena, Javier
Varela Miranda, Rubén E.
D'Vries, Richard F.
dc.contributor.author.none.fl_str_mv Balcázar Morales, Norman
Villamizar Delgado, Stephanny
Porras Osorio, Laura M.
Piñeros, Octavio
Ellena, Javier
Varela Miranda, Rubén E.
D'Vries, Richard F.
dc.contributor.researchgroup.spa.fl_str_mv Genética Molecular (GENMOL)
dc.subject.decs.none.fl_str_mv Hiperglucemia
Hyperglycemia
Biguanidas
Biguanides
Metformina
Metformin
topic Hiperglucemia
Hyperglycemia
Biguanidas
Biguanides
Metformina
Metformin
https://id.nlm.nih.gov/mesh/D006943
https://id.nlm.nih.gov/mesh/D001645
https://id.nlm.nih.gov/mesh/D008687
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D006943
https://id.nlm.nih.gov/mesh/D001645
https://id.nlm.nih.gov/mesh/D008687
description ABSTRACT: Coordination compounds of Cu(ii), Ni(ii), Co(ii), and Zn(ii) with a type of biguanide (known commercially as metformin) have been synthesized and characterized using spectroscopic techniques (FT-IR, UV/VIS), X-ray diffraction techniques and thermal analysis. For all compounds, single crystals were obtained for single-crystal X-ray diffraction. For the first time, an octahedral cobalt compound with the formula [Co(C4H11N5)3]Cl2·2H2O that crystallizes in the monoclinic space group C2/c with one molecule in the asymmetric unit has been obtained. Also, a novel nickel compound with the formula [Ni(C4H11N5) (C4H10N5)]Cl·H2O that crystallizes in the monoclinic space group P21/c with two molecules in the asymmetric unit was obtained. Finally, we obtained copper and zinc compounds that crystallize in the monoclinic space groups P21/n and P21/c with the general formula [Cu(C4H11N5)2]Cl2·H2O and [Zn(C4H12N5)Cl3], respectively. A structural and supramolecular analysis was developed for all compounds using Hirshfeld surface analysis and electrostatic potential maps. The cell viability of the obtained compounds was evaluated in C2C12 (ATCCCRL-1772™) mouse muscle cells and HepG2 (ATCC HB-8065™) human liver carcinoma cells by the MTT assay to determine the potential of the compounds as new safe drugs. The results demonstrate that the compounds exhibit low cytotoxicity at doses less than 250 μg mL-1 with a cell viability greater than 80%.
publishDate 2020
dc.date.issued.none.fl_str_mv 2020
dc.date.accessioned.none.fl_str_mv 2024-08-12T01:09:44Z
dc.date.available.none.fl_str_mv 2024-08-12T01:09:44Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Adv. 2020 Jun 16;10(38):22856-22863. doi: 10.1039/d0ra04059b. PMID: 35514600; PMCID: PMC9054726.
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/41104
dc.identifier.doi.none.fl_str_mv 10.1039/d0ra04059b
dc.identifier.eissn.none.fl_str_mv 2046-2069
identifier_str_mv Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Adv. 2020 Jun 16;10(38):22856-22863. doi: 10.1039/d0ra04059b. PMID: 35514600; PMCID: PMC9054726.
10.1039/d0ra04059b
2046-2069
url https://hdl.handle.net/10495/41104
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv RSC. Adv.
dc.relation.citationendpage.spa.fl_str_mv 22863
dc.relation.citationissue.spa.fl_str_mv 38
dc.relation.citationstartpage.spa.fl_str_mv 22856
dc.relation.citationvolume.spa.fl_str_mv 10
dc.relation.ispartofjournal.spa.fl_str_mv RSC Advances
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0/
http://creativecommons.org/licenses/by-nc/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 8 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Royal Society of Chemistry
dc.publisher.place.spa.fl_str_mv Cambridge, Inglaterra
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/196a1f72-41d7-4bd9-adb3-6c0c8643a991/download
https://bibliotecadigital.udea.edu.co/bitstreams/8d93dab4-2987-4e75-8dc8-301b0ed9352c/download
https://bibliotecadigital.udea.edu.co/bitstreams/72eec5f3-36c3-45fa-b693-9f60543fa84b/download
https://bibliotecadigital.udea.edu.co/bitstreams/794edbb9-d7ef-4413-9e55-f3b0d71aef77/download
bitstream.checksum.fl_str_mv 44b3aba3bfaa73fd0205fc4810c27a88
8a4605be74aa9ea9d79846c1fba20a33
b0d135122b1c45916bb643f0fedd8fc3
35dfd708ca9b3899bb6c5a7c364fc1af
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052641109409792
spelling Balcázar Morales, NormanVillamizar Delgado, StephannyPorras Osorio, Laura M.Piñeros, OctavioEllena, JavierVarela Miranda, Rubén E.D'Vries, Richard F.Genética Molecular (GENMOL)2024-08-12T01:09:44Z2024-08-12T01:09:44Z2020Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Adv. 2020 Jun 16;10(38):22856-22863. doi: 10.1039/d0ra04059b. PMID: 35514600; PMCID: PMC9054726.https://hdl.handle.net/10495/4110410.1039/d0ra04059b2046-2069ABSTRACT: Coordination compounds of Cu(ii), Ni(ii), Co(ii), and Zn(ii) with a type of biguanide (known commercially as metformin) have been synthesized and characterized using spectroscopic techniques (FT-IR, UV/VIS), X-ray diffraction techniques and thermal analysis. For all compounds, single crystals were obtained for single-crystal X-ray diffraction. For the first time, an octahedral cobalt compound with the formula [Co(C4H11N5)3]Cl2·2H2O that crystallizes in the monoclinic space group C2/c with one molecule in the asymmetric unit has been obtained. Also, a novel nickel compound with the formula [Ni(C4H11N5) (C4H10N5)]Cl·H2O that crystallizes in the monoclinic space group P21/c with two molecules in the asymmetric unit was obtained. Finally, we obtained copper and zinc compounds that crystallize in the monoclinic space groups P21/n and P21/c with the general formula [Cu(C4H11N5)2]Cl2·H2O and [Zn(C4H12N5)Cl3], respectively. A structural and supramolecular analysis was developed for all compounds using Hirshfeld surface analysis and electrostatic potential maps. The cell viability of the obtained compounds was evaluated in C2C12 (ATCCCRL-1772™) mouse muscle cells and HepG2 (ATCC HB-8065™) human liver carcinoma cells by the MTT assay to determine the potential of the compounds as new safe drugs. The results demonstrate that the compounds exhibit low cytotoxicity at doses less than 250 μg mL-1 with a cell viability greater than 80%.Universidad Santiago de CaliCoordenação de Aperfeicoamento de Pessoal de Nível SuperiorNational Council for Scientific and Technological DevelopmentCOL00067238 páginasapplication/pdfengRoyal Society of ChemistryCambridge, Inglaterrahttps://creativecommons.org/licenses/by-nc/4.0/http://creativecommons.org/licenses/by-nc/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Biguanide-transition metals complexes as potential drug for hyperglycemia treatmentArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionHiperglucemiaHyperglycemiaBiguanidasBiguanidesMetforminaMetforminhttps://id.nlm.nih.gov/mesh/D006943https://id.nlm.nih.gov/mesh/D001645https://id.nlm.nih.gov/mesh/D008687RSC. Adv.22863382285610RSC Advances445-621118-146#305190/2017-2RoR:00dxj9a45RoR:00x0ma614RoR:03swz6y49PublicationORIGINALBalcazarNorman_2020_Biguanide_Transition_Metals.pdfBalcazarNorman_2020_Biguanide_Transition_Metals.pdfArtículo de investigaciónapplication/pdf971526https://bibliotecadigital.udea.edu.co/bitstreams/196a1f72-41d7-4bd9-adb3-6c0c8643a991/download44b3aba3bfaa73fd0205fc4810c27a88MD51trueAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/8d93dab4-2987-4e75-8dc8-301b0ed9352c/download8a4605be74aa9ea9d79846c1fba20a33MD52falseAnonymousREADTEXTBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.txtBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.txtExtracted texttext/plain41102https://bibliotecadigital.udea.edu.co/bitstreams/72eec5f3-36c3-45fa-b693-9f60543fa84b/downloadb0d135122b1c45916bb643f0fedd8fc3MD53falseAnonymousREADTHUMBNAILBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.jpgBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.jpgGenerated Thumbnailimage/jpeg17024https://bibliotecadigital.udea.edu.co/bitstreams/794edbb9-d7ef-4413-9e55-f3b0d71aef77/download35dfd708ca9b3899bb6c5a7c364fc1afMD54falseAnonymousREAD10495/41104oai:bibliotecadigital.udea.edu.co:10495/411042025-03-27 01:31:15.462https://creativecommons.org/licenses/by-nc/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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